
A preclinical study on the combined effects of repeated eltoprazine and preladenant treatment for alleviating L-DOPA-induced dyskinesia in Parkinson's disease
Keywords: 5-HT; Serotoninergic; MPTP; 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; NHP; Non-human primate; PD; Parkinson's disease; LID; L-DOPA-induced dyskinesia; L-DOPA; L-3,4-dihydroxyphenylalanine; Parkinson's disease; L-DOPA-induced dyskinesia; 5-HT; Adenosin